Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
63%(5 trials)

Phase Distribution

Ph not_applicable
6
75%
Ph phase_3
2
25%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution8 total trials
Phase 3Large-scale testing
2(25.0%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(8)

Detailed Status

Completed8

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 32 (25.0%)
N/A6 (75.0%)

Trials by Status

completed8100%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8